IRIS
PECCI, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 628
EU - Europa 161
AS - Asia 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 628
IT - Italia 57
IE - Irlanda 46
SE - Svezia 36
SG - Singapore 11
GB - Regno Unito 9
IN - India 5
DE - Germania 4
UA - Ucraina 3
BE - Belgio 2
CN - Cina 2
FI - Finlandia 2
RU - Federazione Russa 2
EU - Europa 1
Totale 808
Salva come PNG Salva come JPEG
Città #
Chandler 118
Des Moines 79
Ashburn 59
Fairfield 44
Dublin 42
New York 40
Turin 19
Seattle 18
Wilmington 18
Woodbridge 16
Ann Arbor 14
Boardman 13
Lawrence 13
Princeton 13
Houston 12
San Diego 12
Washington 12
Cambridge 9
San Mateo 9
Jacksonville 7
Los Angeles 7
Pune 5
Redmond 5
Arnold 4
Fermignano 4
Santa Clara 3
Ancona 2
Brussels 2
Centro 2
Civitanova Marche 2
Fabriano 2
Falls Church 2
London 2
Tolentino 2
Acton 1
Bolton 1
Chiswick 1
Falconara Marittima 1
Genzano di Roma 1
Helsinki 1
Islington 1
Kilburn 1
Limido Comasco 1
Milan 1
New Bedfont 1
Phoenix 1
Saint Petersburg 1
Shenzhen 1
Stockholm 1
Wuhan 1
Totale 627
Salva come PNG Salva come JPEG
Nome #
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 88
Electrolyte disorders in cancer patients: a systematic review 80
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis 75
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 64
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 59
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 57
Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy 57
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC 55
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer 49
Re: Comments on 'High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients' 46
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab 35
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 31
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status 29
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study 23
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 20
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study 18
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 17
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives 16
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study 13
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers 1
Non-small-cell lung cancer: how to manage EGFR-mutated disease 1
Totale 834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.013
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 1 3
2020/2021121 0 3 28 18 14 0 0 7 8 7 17 19
2021/2022122 1 9 1 4 16 12 4 4 25 8 17 21
2022/2023369 19 45 16 32 14 104 0 18 58 11 45 7
2023/2024218 40 8 23 18 31 81 2 5 0 10 0 0
Totale 834